GlassScriptPhysician profile
Milbrey Parke
NPI 1770223299
$1,705.40
in general payments reported to CMS, 2019-2025
10 companies · $461 in 2025
The $461 reported for 2025 was more than what 77% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $567 · 2024: $677 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,705.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $500.49 | 2023-2024 | |
| Almirall LLC | $252.48 | 2023-2024 | Klisyri |
| Novartis Pharmaceuticals Corporation | $146.87 | 2024-2025 | |
| Lilly USA, LLC | $141.87 | 2024-2025 | Olumiant, Ebglyss |
| Arcutis Biotherapeutics, INC. | $135.34 | 2025 | Zoryve |
| Genzyme Corporation | $133.35 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $123.53 | 2024 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.93 | 2023 | Spevigo |
| Krystal Biotech INC | $92.05 | 2023 | Vyjuvek |
| Pfizer INC. | $56.49 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milbrey Parke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.